Tweet
Jakarta Globe
<img alt="" height="1" width="1" />
FDA Panel Endorses Lupus Drug
MedPage Today
ADELPHI, Md. -- An FDA advisory panel has voted 13 to 2 to recommend approval for belimumab (Benlysta) to treat lupus, despite clinical trials of the drug showing only marginal efficacy. ...
FDA Panel Backs Approval Of Human Genome, Glaxo Lupus DrugWall Street Journal
FDA panel backs first new lupus drug in 50 yearsBusinessWeek
BREAKING NEWS: HGS wins crucial panel backing for BenlystaFierceBiotech
Daily Comet -RTT News -Bloomberg
all 538 news articles »
More...